Digital Pathology Market 2019 Is Productization of Digital Pathology Services Way Forward? | Future of Clinical Adoption of Digital Pathology Industry to Reach US$ 1,045.41 Million by 2025, growing at a CAGR of 12% from 2019-2025

Digital Pathology Market 2019-2025: Digital Pathology Marketwas valued at US$ 383.1 million in 2016 and is anticipated to surpass US$ 1,045.41 Million by 2025, growing at a CAGR of 11.8% from 2016 to 2025.

Get a Quick Sample PDF Brochure of this report at https://decisionmarketreports.com/request-sample?productID=950282

Competitive Landscape: The major players in the market are as follows:
1. Leica Biosystems
2. Ventana Medical Systems
3. Hamamatsu Photonics
4. 3DHISTECH
5. Koninklijke Philips
6. Apollo Enterprise Imaging
7. XIFIN
8. Huron Digital Pathology
9. Visiopharm
10. Corista
11. Indica Labs
12. Objective Pathology Services

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Browse Complete Report with Table of Content at https://decisionmarketreports.com/market-reports/950282/global-digital-pathology-market

Digital pathology is an image-based information environment which is enabled by computer technology that allows for the management of information generated from a digital slide. Digital pathology is enabled in part by virtual microscopy, which is the practice of converting glass slides into digital slides that can be viewed, managed, and analyzed on a computer monitor. With the advent of Whole-Slide Imaging, the field of digital pathology has exploded and is currently regarded as one of the most promising avenues of diagnostic medicine in order to achieve even better, faster and cheaper diagnosis, prognosis and prediction of cancer and other important diseases.Medical centers are investing in the market to reduce the costs associated with drug trials and risks, and to get accurate results.

1. Market Drivers
1.1 Increasing usage of digital pathology
1.2 Increased efforts to enhance lab ethics and quality
1.3 Increased cases of cancer and need in drug developments
1.4 Ease of consultation
1.5 Increased interest of government and market players on technology usage

2. Market Restraints
2.1 High implementation cost
2.2 Lack of IT specified guidelines

Market Segmentation:
Digital Pathology Marketis segmented on the basis of:
1. Digital Pathology Market, byType:

1.1 Human Pathology
1.2 Veterinary Pathology

2. Digital Pathology Market, by end user:
2.1 Pharmaceutical and Biotechnology Companies
2.2 Academic and Government Research Institutes
2.3 Hospitals
2.4 Others

3. Digital Pathology Market, Application :
3.1 Teleconsultation
3.2 Disease Diagnosis
3.3 Drug Discovery
3.4 Training and education
3.5 Others

4. Digital Pathology Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, Japan, India, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5Rest of the World

To know more about methodology of this report at: https://decisionmarketreports.com/request-methodolgy?productID=950282

Table of Content

1 INTRODUCTION OF GLOBAL DIGITAL PATHOLOGY MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL DIGITAL PATHOLOGY MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL DIGITAL PATHOLOGY MARKET, BY TYPE
5.1 Overview
5.2 Human Pathology
5.3 Veterinary Pathology

6 GLOBAL DIGITAL PATHOLOGY MARKET, BY END-USER
6.1 Overview
6.2 Pharmaceutical and Biotechnology Companies
6.3 Academic and Government Research Institutes
6.4 Hospitals
6.5 Others

7 GLOBAL DIGITAL PATHOLOGY MARKET, BY APPLICATION
7.1 Overview
7.2 Teleconsultation
7.3 Disease Diagnosis
7.4 Drug Discovery
7.5 Training and education
7.6 Others

8 GLOBAL DIGITAL PATHOLOGY MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 – 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 – 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 – 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 – 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 – 2025

9 GLOBAL DIGITAL PATHOLOGY MARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Leica Biosystems
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Ventana Medical Systems
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Hamamatsu Photonics
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 3DHISTECH
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Koninklijke Philips
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Apollo Enterprise Imaging
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 XIFIN
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Huron Digital Pathology
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Visiopharm
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Corista
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

10.11 Indica Labs
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments

10.12 Objective Pathology Services
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments

11 Appendix
11.1 Related Reports

Request a In-depth Insights PDF Sample Brochure @ https://decisionmarketreports.com/request-sample?productID=950282

About Us
Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

Contact Us
Gasper James
304, S Jones Blvd,
Las Vegas,
NV 89107, USA
US Toll Free +1-866-605-1052
Email: sales@decisionmarketreports.com
Web: https://decisionmarketreports.com

This release was published on openPR.